Provided by Tiger Trade Technology Pte. Ltd.

Cytokinetics

73.62
-0.4900-0.66%
Pre-market: 73.05-0.5733-0.78%04:06 EDT
Volume:1.44M
Turnover:106.88M
Market Cap:10.23B
PE:-10.25
High:75.10
Open:73.23
Low:73.13
Close:74.11
52wk High:88.31
52wk Low:47.22
Shares:139.02M
Float Shares:138.02M
Volume Ratio:0.94
T/O Rate:1.05%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.1827
EPS(LYR):-6.5400
ROE:-572.15%
ROA:-28.09%
PB:-59.00
PE(LYR):-11.26

Loading ...

Press Release: Cytokinetics Announces Closing of Public Offering of Common Stock and Full Exercise of the Underwriters' Option to Purchase Additional Shares for Gross Proceeds of $805 Million

Dow Jones
·
May 08

BUZZ-U.S. STOCKS ON THE MOVE-Krispy Kreme, Tesla, Axon Enterprise

Reuters
·
May 08

Cytokinetics Inc : Jefferies Raises Target Price to $105 From $90

THOMSON REUTERS
·
May 07

BUZZ-U.S. STOCKS ON THE MOVE-Catalyst Pharma, DoorDash, Tapestry

Reuters
·
May 07

Cytokinetics (CYTK) Gets a Buy from Wells Fargo

TIPRANKS
·
May 07

Cytokinetics price target raised to $119 from $101 at RBC Capital

TIPRANKS
·
May 07

Cytokinetics price target raised to $103 from $90 at Morgan Stanley

TIPRANKS
·
May 07

BRIEF-Cytokinetics Prices Public Offering Of 9.8 Mln Shares At $71/Share

Reuters
·
May 07

Cytokinetics prices upsized follow-on offering of 9,859,155 shares at $71 each

Reuters
·
May 07

Cytokinetics Announces Pricing of Upsized Public Offering of Common Stock

THOMSON REUTERS
·
May 07

Cytokinetics Is Maintained at Overweight by Morgan Stanley

Dow Jones
·
May 07

Cytokinetics' Rapid Growth of Myqorzo not Fully Priced in by Investors, RBC Says

MT Newswires Live
·
May 07

BUZZ-Cytokinetics slides on stock sale plans following heart disease study

Reuters
·
May 07

RBC Adds Speculative Risk to Outperform Rating on Cytokinetics, Lifts Price Target to $119 From $101

MT Newswires Live
·
May 06

Cytokinetics Inc : RBC Raises Target Price to $119 From $101

THOMSON REUTERS
·
May 06

Cytokinetics Inc : Needham Raises Target Price to $102 From $85

THOMSON REUTERS
·
May 06

Cytokinetics Earnings Call Highlights Launch, Trial Wins

TIPRANKS
·
May 06

Cytokinetics EVP R&D Malik Fady Ibraham disposes 3,500 shares worth $270,795

Reuters
·
May 06

Cytokinetics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 06

BRIEF-Cytokinetics Inc - Offers Common Stock With Aggregate Public Offering Price Of $650 Million - SEC Filing

Reuters
·
May 06